Back to search

University of Thessaly (UTH)

Γενετικοί και επιγενετικοί παράγοντες στην οστεοαρθρίτιδα: ο ρόλος των microRNAs

Abstract

dc:description

Osteoarthritis (OA) is the most common chronic degenerative joint disease, causing significant pain and disability. It affects all joints in the body with the knee joint bearing the greatest burden. OA affects structural elements of the joint, characterized by degeneration of joint cartilage, formation of osteophytes, subchondral bone sclerosis, and synovial membrane hypertrophy. Globally, it is estimated that around 500 million people suffer from OA. Various risk factors such as aging, obesity, gender, joint injury, and heredity have been associated with the development and progression of OA. However, the precise molecular mechanisms underlying OA pathogenesis remain unclear. Despite the significant burden of OA on patients and healthcare systems, there are currently no sensitive biomarkers for early detection of the disease, nor effective therapeutic options apart from joint replacement surgery (knee or hip) in advanced stages of the disease. The standard method for diagnosing and assessing the severity of knee OA is through radiography based on the Kellgren/Lawrence grading scale. Therefore, there is a need to identify non-invasive and sensitive biomarkers for the early prediction and diagnosis of OA, for the early treatment and the optimization of the clinical management of the disease. Recent studies have reported that small non-coding RNAs called microRNAs (miRNAs) are considered as promising biomarkers for various diseases such as cancer, diabetes, cardiovascular diseases, and OA. MiRNAs are a group of small non-coding RNA molecules, approximately 22-28 nucleotides in length, that regulate gene expression post-transcriptionally by degrading or inhibiting the translation of target mRNAs. Each miRNA can target multiple genes by binding primarily to the 3' untranslated region (UTR) of their target mRNAs. MiRNAs are involved in processes related to OA pathogenesis, such as cartilage homeostasis, regulation of the extracellular matrix, osteogenesis, bone metabolism, apoptosis, inflammation, and lipid metabolism. Additionally, miRNAs have been found in circulation, suggesting their potential as biomarkers. They can be transported through microvesicles, exosomes, protein complexes like Ago, or high-density lipoproteins (HDL), reflecting the cellular content or mediating intercellular signaling, providing valuable information about the pathophysiological state of cells. MiRNAs are attractive as biomarkers due to their stability, tissue-specific expression, non-invasive detection, and regulation of gene expression. Furthermore, advances in molecular biology techniques have facilitated sensitive and accurate detection of miRNAs. Microarray technology is a valuable tool for investigating miRNA expression profiles and their role in the pathogenesis of various diseases. Moreover, miRNAs represent potential therapeutic targets for developing personalized therapeutic strategies for the disease. Specifically, hsa-miR-140, extensively studied in OA, plays a significant role in chondrocyte homeostasis and chondrogenesis. It has been reported to show differential expression in OA cartilage and synovial fluid but not in serum. Hsa-miR-140 generates two mature microRNAs: hsa-miR-140-5p and hsa-miR-140-3p.The aim of the present thesis is the investigation of miRNAs involved in significant processes related to OA pathogenesis, in the serum of individuals with knee osteoarthritis (OA) and the identification of implicated mechanisms controlling their actions. The goal was to highlight miRNAs that could emerge as potentially important prognostic/diagnostic biomarkers for OA. Cartilage samples from patients with primary osteoarthritis who had undergone total knee arthroplasty were used. Patients with rheumatoid arthritis or arthritis and other autoimmune diseases, as well as chondrodysplasia, septic OA and post-traumatic OA were excluded from the study. For the control group, cartilage samples were obtained from individuals, with no history of joint disease, who had undergone severe fracture repair surgery or amputation. More precisely, a comprehensive analysis of miRNA expression profiles was conducted using high-density miRNA arrays in the serum of OA patients compared to healthy individuals. The Agilent Human miRNA Microarray platform, interrogating 2,549 miRNAs, was used. ROC curves were constructed to evaluate the diagnostic value of the differentially expressed miRNAs in the serum of OA patients and healthy individuals. The expression levels of specific miRNAs, which showed the greatest differences in the serum between OA and the control group, such as hsa-miR-33b-3p, hsa-miR-4284, hsa-miR-663a, hsa-miR-150-5p, hsa-miR-1233-3p, hsa-miR-140-3p, and hsa-miR-671-3p, were validated in samples of articular cartilage from the same individuals. Bioinformatics tools were used to investigate the predicted molecular signaling pathways and the target genes of the differentially expressed miRNAs. Subsequently, hsa-miR-140-3p was selected to further investigate its role in OA. Protein-protein interaction networks of the target genes of hsa-miR-140-3p were constructed using bioinformatics tools. Transfection of OA chondrocytes with miR-140-3p mimic was performed, and its impact on the transcriptional levels of potential target genes such as PTEN, TGFa, BCL-2, SIRT-1, HMGCR and HDAC4, as well as molecular markers related to cartilage homeostasis, specifically MMP-13, TNFA, and COL2A1, was investigated. The results of the thesis revealed 279 miRNAs deregulated in the serum of OA patients compared to the control group, 205 miRNAs (73.5%) showed increased expression and 74 miRNAs (26.5%) exhibited decreased expression. ROC analysis identified 77 miRNAs with AUC>0.8 and p-values<0.05, indicating their diagnostic potential. Bioinformatics analysis of these 77 miRNAs revealed their involvement in multiple signaling pathways related to OA, such as FoxO, mTOR, Wnt, PI3K/Akt, adipocytokine, TGF-β, ECM receptor, and fatty acid biosynthesis pathways. The expression levels of the selected miRNAs (hsa-miR-33b-3p, hsa-miR-4284, hsa-miR-663a, hsa-miR-150-5p, hsa-miR-1233-3p, hsa-miR-140-3p, and hsa-miR-671-3p) were validated with qRT-PCR, showing reduced expression of three miRNAs (hsa-miR-33b-3p, hsa-miR-671-3p, and hsa-miR-140-3p) in the serum of OA patients compared to healthy individuals. Hsa-miR-140-3p and hsa-miR-671-3p expression levels were consistently downregulated in articular cartilage of OA patients compared to healthy individuals, confirming their presence in the OA joint environment. Through bioinformatics analysis, the target genes of hsa-miR-140-3p associated with osteoarthritis were identified. Notably, significant protein-protein interaction networks involving these target genes were discovered through network topology analysis and pathway-gene ontology analysis. Considering these bioinformatics findings, PTEN emerged as a gene displaying high connectivity in the PPI network and involvement in multiple pathways/processes crucial for OA. Furthermore, the analysis of the 3' UTR mRNA of PTEN to identify functional binding sites of hsa-miR-140-3p, using the bioinformatics tool TargetScanHuman 8.0, revealed the presence of specific sequences recognized by hsa-miR-140-3p. Specifically, two complementary sequences for miR-140-3p were found in the 3' UTR of PTEN, at positions 1763-1769 and 2882-2888. Treatment of OA chondrocytes with miR-140-3p mimic (100 nM) for 72 hours resulted in significant reduction of PTEN mRNA expression levels compared to untreated cells. These findings combined with the results showing increased PTEN transcriptional levels and decreased hsa-miR-140-3p levels in osteoarthritic chondrocytes compared to normal, indicate an inverse correlation between these two molecules, highlighting the role of miR-140-3p in PTEN regulation, and a potential molecular mechanism contributing to the differential expression of PTEN in OA cartilage. Moreover, treatment of OA chondrocytes with miR-140-3p mimic resulted in significantly decreased HMGCR, HDAC4, and MMP-13 mRNA expression levels and increased BCL-2 mRNA expression levels compared to untreated cells. In conclusion, a signature of three miRNAs (hsa-miR-140-3p, hsa-miR-671-3p, and hsa-miR-33b-3p) was identified in the serum of OA patients using miRNA microarrays. These miRNAs could be considered as potential biomarkers for assessing the risk and progression of OA. Additionally, hsa-miR-140-3p was identified not only as a biomarker but also as a potential therapeutic target for osteoarthritis. The use of miR inhibitors or mimics has been shown to have therapeutic benefits in preclinical (animal) models of the disease, indicating that it is a promising approach for slowing down the progression of OA at early stages.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ntoumou, Eleni
  • Ντούμου, Ελένη

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55217

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ntoumou, Eleni; Ντούμου, Ελένη. Γενετικοί και επιγενετικοί παράγοντες στην οστεοαρθρίτιδα: ο ρόλος των microRNAs. University of Thessaly (UTH), 2023. http://hdl.handle.net/10442/hedi/55217